A recent study published in the journal Microbiome has uncovered an interesting discovery in NASA’s cleanrooms: new species ...

The French biotechnology firm aims to develop therapies for various neurological conditions using its non-replicating HSV-1 vector technology.

Bio-Techne surpasses profit expectations with significant growth in its research products, leading to the announcement of a ...

Now is the time for the biotechnology sector to ask for big changes to the FDA, NIH, reimbursement, intellectual property and ...

Grit Biotechnology Co., Ltd. ('Grit Bio'), a clinical-stage biotech pioneering novel immunotherapies announced today that three research programs, in collaboration with Vitalgen BioPharma Co., Ltd.

Discover how a flexible protein can rearrange itself to multitask efficiently, revolutionizing medicine, agriculture, and ...

Natural products are among the most promising candidates for the development of new drugs. However, due to their structural complexity, they are often difficult to access.

Some of these new regulations have been more successful ... would need to be very diligently substantiated. HB: What advances in biotech regulations do you expect we will see over the next 10 ...

IO Biotech's co-founder presented advancements in cancer vaccines at ... The company is headquartered in Copenhagen with a U.S. office in New York. Dr. Mads Hald Andersen’s prominence in the ...

Moleculin Biotech, Inc. announced that the World Health ... and 6 decrease their positions in their most recent quarter. . Annamycin is currently in development for the treatment of relapsed ...

China’s focus on agri-biotechnology has been ... has translated into significant advancements in genetically modified crops, with China approving 15 new GM varieties in 2024 alone such as ...

Investors are already returning to biotech, because of these and many other advances, and this is the best entrance into the new millennium that we as practitioners could have hoped.